Security key
89422G107
Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TVTX)
CUSIP: 89422G107
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 92,930,114
- Total 13F shares
- 100,727,863
- Share change
- -180,642
- Total reported value
- $2,407,390,168
- Put/Call ratio
- 40%
- Price per share
- $23.90
- Number of holders
- 235
- Value change
- +$19,761,610
- Number of buys
- 125
- Number of sells
- 105
Report period
Q3 2025
Institutions
235
Top holders
10
TVTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Travere Therapeutics, Inc. SEC filings
Travere Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 89422G107
Recent filing periods:
Ownership snapshot
Top shareholders of TVTX - Travere Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
JANUS HENDERSON GROUP PLC
13D/G signal
JANUS HENDERSON GROUP PLC
Evidence rows
50
Latest as of
30 Sep 2025
13D/G
13F
Lead comparable stake: 12%
13D/G row: JANUS HENDERSON GROUP PLC
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
Company
|
12%
|
$253,331,874
10,599,660 shares
|
-$17,690,876 | 30 Sep 2025 |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$133,187,551
11,025,471 shares
mixed-class rows
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
7.5%
|
$122,617,344
6,689,435 shares
|
-$24,357,949 | 31 Mar 2025 |
| Rock Springs Capital Management LP |
13D/G
13F
Company
|
3.3%
|
$53,545,523
2,921,196 shares
|
-$37,621,463 | 31 Mar 2025 |
| Woodline Partners LP |
13D/G
13F
Company
|
2.4%
|
$38,750,646
2,114,056 shares
|
$0 | 31 Dec 2024 |
| MACQUARIE GROUP LTD |
13F
Company
|
5.5%
|
$75,443,000
5,097,482 shares
|
— | 30 Jun 2025 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
3%
|
$41,203,200
2,784,000 shares
|
— | 30 Jun 2025 |
| EMERALD ADVISERS, LLC |
13F
Company
|
2.3%
|
$30,952,128
2,091,360 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
235
Shares
100,727,863
Rows loaded
237
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
207
Q3 2025 holders
235
Holder diff
28
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend